Contraindicated initiation of β-blocker therapy in patients hospitalized for heart failure

JAMA Internal Medicine

Volumn 173, Issue 16, 2013, Pages 1547-1549

  Dharmarajan, Kumar ^a,d   Masoudi, Frederick A ^b   Spertus, John A ^c   Li, Shu Xia ^d   Krumholz, Harlan M ^d,e,f  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d YALE NEW HAVEN HOSPITAL   (United States)

^e YALE UNIVERSITY   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DOBUTAMINE; DOPAMINE; LOOP DIURETIC AGENT; METOPROLOL SUCCINATE; MILRINONE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; EMERGENCY CARE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION; TREATMENT CONTRAINDICATION; UNITED STATES;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CARDIOTONIC AGENTS; COHORT STUDIES; DRUG UTILIZATION; HEART FAILURE; HOSPITALIZATION; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; UNITED STATES;

EID: 84883790309     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.7717     Document Type: Article

References (8)

1. Bonow RO, Ganiats TG, Beam CT, et al American College of Cardiology Foundation; American Heart Association Task Force on Performance Measures; American Medical Association-Physician Consortium for Performance Improvement. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure. Circulation. 2012;125(19):2382-2401.
2. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4):349-361. (Pubitemid 41132339)
3. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010;303(23):2359-2367.
4. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure, part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002;105(11):1387-1393. (Pubitemid 34260433)
5. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33(7):1948-1955.
6. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW; ADHERE Scientific Advisory Committee and Investigators. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007;153(6):1021-1028. (Pubitemid 46809844)
7. Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest. 2007;131(6):1865-1869. (Pubitemid 46981647)
8. Baker DW, Qaseem A; American College of Physicians' Performance Measurement Committee. Evidence-based performance measures: preventing unintended consequences of quality measurement. Ann Intern Med. 2011;155(9):638-640.